CD70 and neoplasm: In vivo, co-injection of CD70-expressing fibroblasts with cSCC cells accelerates tumor growth, whereas CD70 knockdown impairs tumor progression and reduces PCNA, IL6, and MCP3 expression, confirming its functional relevance in the tumor microenvironment.